The AbbVie Foundation, a nonprofit dedicated to addressing health inequities, has made a $75 million donation to the University of Chicago to support the construction of UChicago Medicine’s new cancer pavilion—the first freestanding facility in Illinois dedicated to reshaping cancer care.
The building, to be named the AbbVie Foundation Cancer Pavilion when it opens in 2027, reflects the shared mission of both organizations to advance health equity and increase access to high-quality, culturally competent care. The donation helps fund the $815 million, 575,000-square-foot building, which will serve as UChicago Medicine’s flagship hub where the organization will advance the field of cancer through world-class research, pioneering clinical treatments and personalized patient care — all under one roof.
“We are deeply honored by this generous donation, as it strengthens our commitment to advancing the health and vitality of the community — a core priority of our South Side-based institution,” said President Paul Alivisatos. “This significant contribution speaks to the confidence that the AbbVie Foundation has in UChicago as a pioneering medical institution dedicated to pursuing globally meaningful solutions to yet-unsolved challenges.”
To read more from UChicago News, click here.
